CD274 and non-small cell lung carcinoma: These SNPs have been studied for their clinical potential in NSCLC and it has been reported that the co-existence of the rs822336C and rs822337A haplotypes is associated with worse survival, as well as with significantly lower promoter activity and thus with downregulation of PD-L1 [30].